Native Drugs Private Limited

Native Drugs Private Limited - pharma in Amritsar, Punjab, India. FY 2026 financials & compliance.
CIN U74899PB1990PTC047094 Incorporated 23 February 1990 ROC Chandigarh HQ Amritsar, Punjab, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2025
₹1.49 Cr
▼ 20% YoY
Net profit · FY 2025
₹2.48 Lakh
Net margin 1.7%
EBITDA · FY 2025
₹26.38 Lakh
EBITDA margin 17.7%
Authorised capital
₹7 Lakh
Registered with MCA
Paid-up capital
₹6.93 Lakh
Issued & subscribed
Open charges
₹50 Lakh
Satisfied ₹1.03 Cr
Company age
36 yrs
Est. 1990
Directors on board
2
As per MCA filings

About Native Drugs Private Limited

Data last updated:

Native Drugs Private Limited is a private limited company based in Amritsar, Punjab, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 February 1990 and has been in existence for over 36 years.

The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U74899PB1990PTC047094. Its GSTIN is 03AAACN5585G1ZJ (Punjab).

The company has an authorised share capital of ₹7 Lakh and a paid-up capital of ₹6.93 Lakh. It is led by directors Usha Aggarwal and Ashok Kumar Aggarwal.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Native Drugs Private Limited Near Silver Estate Vijay Vihar, Amritsar, Punjab, India – 143001.

As per the financials filed for FY 2025, the company reported a revenue of ₹1.49 Cr, a decline of 20% compared to the previous year. For the same year it recorded a net profit of ₹2.48 Lakh (net margin 1.7%) and EBITDA of ₹26.38 Lakh (EBITDA margin 17.7%). Revenue has declined at a compounded annual rate (CAGR) of 13% over three years and 1% over five years.

As per MCA filings, the company has open charges of ₹50 Lakh and satisfied charges of ₹1.03 Cr on record. Court records list 17 cases involving the company, including 16 filed by the company and 1 filed against it.

Native Drugs Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-PB-01-0015681). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U74899PB1990PTC047094
Registration Number 047094
Incorporation Date 23 February 1990
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-PB-01-0015681

CIN history

Native Drugs has one previous CIN (Corporate Identification Number): U74899DL1990PTC039320. The current CIN is U74899PB1990PTC047094, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U74899PB1990PTC047094Current
U74899DL1990PTC039320Previous
Key People
Usha Aggarwal Director Ashok Kumar Aggarwal Director

Recognitions & Rankings of Native Drugs

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-PB-01-0015681

Contact details

Native Drugs Private Limited's registered office is in Amritsar, Punjab. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Native Drugs Private Limited Near Silver Estate Vijay Vihar, Amritsar, Punjab, India – 143001
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Native Drugs Private Limited, buy the company report.

Comprehensive company report
Native Drugs Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Native Drugs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Native Drugs Private Limited, buy the company report.

Financials of Native Drugs Private Limited

FY 2024 filings available

Native Drugs Private Limited reported revenue of ₹1.49 Cr (down 20% YoY) for FY 2025.

Revenue · FY 2025
₹1.49 Cr ▼ 20%
Net profit · FY 2025
₹2.48 Lakh margin 1.7%
EBITDA · FY 2025
₹26.38 Lakh margin 17.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 20%
3 years · compounded
▼ 13%
5 years · compounded
▼ 1%
EBITDA CAGR growth
1 year
▲ 11%
3 years · compounded
▲ 11%
5 years · compounded
▲ 5%

Revenue has declined at a compounded annual rate (CAGR) of 1% over five years, including a 20% fall in the latest year. EBITDA rose 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹26.38 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹2.48 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin17.7%
Net Profit Margin1.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Native Drugs Private Limited, buy the company report.

Board of directors of Native Drugs Private Limited

Native Drugs has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Usha AggarwalDirector24 May 200224 Years 5 MonthsCurrent
Ashok Kumar AggarwalDirector24 May 200224 Years 5 MonthsCurrent
View all directors

Peer comparison

Native Drugs Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Providence Lifesciences Private Limited₹1.5 Cr (FY 2024)137392.0%Nagpur, Maharashtra, India
Chemixl Intermediates Private Limited₹1.49 Cr (FY 2025)-41.0%Umargam, Gujarat, India
Native Drugs Private Limitedthis company₹1.49 Cr (FY 2025)₹2.48 Lakh1.7%-20.0%Amritsar, Punjab, India
Marvel Medilinks Private Limited₹1.48 Cr (FY 2024)4.0%Punjab, India
Harisons Pharmaceuticals Limited₹1.48 Cr (FY 2025)-7.0%Chandigarh, India

To see the full peer comparison of Native Drugs Private Limited, buy the company report.

Auditor

Native Drugs Private Limited is audited by Vikas Kalra & Co. for the financial year 2024.

Auditor firmFinancial yearFirm registration number
Vikas Kalra & Co.FY 2024012585N

Shareholding

The shareholding of Native Drugs Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Native Drugs Private Limited, buy the company report.

Charges & borrowings

Open charges
₹50 Lakh
Satisfied charges
₹1.03 Cr
Breakdown by lending institutions
Others₹0.50 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
04 Mar 201410494448Others₹50 LakhOpen
01 Jul 2016100053456Others₹19 LakhSatisfied
04 Jun 201110290168State Bank of India₹50 LakhSatisfied
13 Sep 200490050891State Bank of India₹32.3 LakhSatisfied
14 Jan 199990047378Dena Bank₹1.5 LakhSatisfied

To see the full charge records of Native Drugs Private Limited, buy the company report.

Total charge records: 5 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Native Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Native Drugs has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
03AAACN5585G1ZJPunjabActive01 Jul 2017

To see the full GST registrations and return filing status of Native Drugs Private Limited, buy the company report.

Recent activity

Native Drugs Private Limited has 2 board changes on record since 2002: 2 appointments. The latest: Ashok Kumar Aggarwal was appointed as Director on 24 May 2002.

AGM
Native Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Native Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh.
Charges
A charge with Others of Rs. 50.00 Lakh registered on 04 Mar 2014 with Charge ID 10494448 was modified on 29 Jun 2022.
Charges
A charge registered on 14 Jan 1999 via Charge ID 90047378 with Dena Bank was fully satisfied on 29 Jul 2021.
Charges
A charge registered on 01 Jul 2016 via Charge ID 100053456 with Others was fully satisfied on 04 Jun 2020.
Charges
A charge with Others amounted to Rs. 19.00 Lakh with Charge ID 100053456 was registered on 01 Jul 2016.
Charges
A charge registered on 04 Jun 2011 via Charge ID 10290168 with State Bank Of India was fully satisfied on 05 Mar 2014.
Charges
A charge with Others amounted to Rs. 50.00 Lakh with Charge ID 10494448 was registered on 04 Mar 2014.
Charges
A charge with State Bank Of India amounted to Rs. 50.00 Lakh with Charge ID 10290168 was registered on 04 Jun 2011.
Charges
A charge registered on 13 Sep 2004 via Charge ID 90050891 with State Bank Of India was fully satisfied on 04 Jun 2011.
Charges
A charge with State Bank Of India of Rs. 32.30 Lakh registered on 13 Sep 2004 with Charge ID 90050891 was modified on 29 Jul 2006.
Charges
A charge with State Bank Of India amounted to Rs. 32.30 Lakh with Charge ID 90050891 was registered on 13 Sep 2004.

4 earlier events are in the company report.

Frequently asked questions

Native Drugs is an active private limited company based in Amritsar, Punjab, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 February 1990 (36+ years old) and is registered under CIN U74899PB1990PTC047094.

Native Drugs has 2 current directors:

The latest financial statements of Native Drugs on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Native Drugs is 03AAACN5585G1ZJ, registered in Punjab.

The CIN (Corporate Identification Number) of Native Drugs is U74899PB1990PTC047094. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Native Drugs has 17 court cases on record: 16 filed by the company and 1 filed against it. Most are in the district courts.

Native Drugs was incorporated on 23 February 1990, making it 36+ years old. It is registered with the Registrar of Companies, Chandigarh.

The peers of Native Drugs by revenue are Providence Lifesciences Private Limited, Chemixl Intermediates Private Limited, Marvel Medilinks Private Limited, Harisons Pharmaceuticals Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Ashok Kumar Aggarwal was appointed as Director on 24 May 2002. Usha Aggarwal was appointed as Director on 24 May 2002.

Yes, Native Drugs is registered as a micro enterprise under Udyam registration (number: UDYAM-PB-01-0015681).

The registered office of Native Drugs is at Native Drugs Near Silver Estate Vijay Vihar, Amritsar, Punjab, India – 143001.